Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001193125-26-389892

Chief Medical Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Karlin Daniel · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-14 Grant or award : show line 1 in the form +200,000 803,699 D
Loading xslF345X06/ownership.xml…